Beyond The GLP-1 Injection
As conditions like type 2 diabetes (T2D) and obesity reach concerning levels, so has been the demand for effective solutions. There is now a rise in medications like glucagon-like peptide-1 (GLP-1) receptor agonists, proven to help treat these issues. Pharmacies unable to meet demand due to delays from manufacturers are turning to compounding. Today’s patient wants support beyond the standard injectables. Studies show GLP-1 can be effective in other forms, opening new doors to personalized care. Pharmacies must begin to embrace these changes by creating these custom options to meet the needs of patients. Compounding expands options, meets demand, and helps pharmacies improve patient experience.
Form follows function
While GLP-1 solutions can help treat type 2 diabetes and weight loss, consistent use is required to be effective. Medication adherence continues to be a major challenge as some patients struggle with using the standard forms of GLP-1. Some patients may want to avoid injectables, the standard form of this medication, due to preference. Compounding adapts GLP-1s for better adherence. The pharmacy can create an oral form, sublingual troches, or transdermal creams. The form depends on the patient’s unique needs and tolerability. The flexibility of compounding means GLP-1 can be formulated in doses to meet specific schedules or included as part of a multi-drug strategy. As GLP-1 can now be compounded into different forms, pharmacies can improve patient experience without sacrificing effectiveness.
From intolerance to innovation
There has been growing concern about GLP-1 side effects, which can lead to complications or impact medication adherence. Some of these are related to additional ingredients within GLP-1 formulations. Gastrointestinal distress, nausea, and vomiting, for instance, are common reasons patients discontinue GLP-1 use. These side effects underscore the fact that drugs impact everyone differently depending on factors such as health, genetics, and the use of other medications. Compounding allows patients to use GLP-1 while minimizing the side effects as a custom option keeps these sensitivities in mind. Removing allergens, adjusting delivery speed, or supportive agents reduce discomfort. Patients can remain on therapy longer, feel more comfortable, and improve long-term metabolic outcomes.
Not just weight loss
Using GLP-1 and other medications is not only about weight loss. These drugs can help maintain the long-term health of patients. The mass-produced options do not depend on the unique factors of patients. Compounding produces custom dosing for unique metabolic needs. Factors like weight, comorbidities, age, and health goals are considered when compounding. Proper titration may reduce the risk of side effects and improve glycemic control over time. GLP-1 is also helpful in broader metabolic applications. Studies show that there are benefits in conditions like polycystic ovarian syndrome (PCOS), cardiovascular health, and metabolic syndrome. Compounding expands access to more patients in a range of health applications.
A tailored approach to treatment
GLP-1 medication has created a new frontier in type 2 diabetes management and off-label for weight loss purposes. The standard forms, like injectables, are effective but have limitations. Compounding helps pharmacies to provide GLP-1 while addressing unique needs. These pharmacists can recreate GLP-1 with stability, sterility, and potency in mind. From changing the form to oral options to removing specific ingredients, patient-centered care is possible.
